Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma

NCT00061035 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Neoplasms

Interventions

BIOLOGICAL: Transgenic Lymphocyte Immunization Vaccine (TLI)

Sponsor

Cosmo Bioscience